Investing.com - Bicycle Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Bicycle Therapeutics announced earnings per share of $-0.59 on revenue of $4.33M. Analysts polled by Investing.com anticipated EPS of $-0.611 on revenue of $5.75M.
Bicycle Therapeutics shares are up 214.93% from the beginning of the year and are trading at $56.53 , down-from-52-week-high.They are outperforming the Nasdaq which is up 22.68% from the start of the year.
Bicycle Therapeutics follows other major Healthcare sector earnings this month
Bicycle Therapeutics's report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on October 27 with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.38B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar